Why a 6-Day Half-Life Enables Once-Weekly Dosing With a half-life of 6 days, a meaningful fraction of each dose is still circulating when the next injection is due
10.1038/s41598-017-05541-4 104 WangW.MarinisJ
CrossRef Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo Clinical Cancer Research .2025
Duration: For visible results, use consistently for at least 48 weeks